1. Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
- Author
-
Hemminger J, Balada-Llasat JM, Raczkowski M, Buckosh M, and Pancholi P
- Subjects
- Adult, Aged, 80 and over, Amikacin therapeutic use, Bacteremia diagnosis, Bacteremia epidemiology, Bacteremia microbiology, Clostridioides difficile drug effects, Clostridium Infections diagnosis, Clostridium Infections epidemiology, Clostridium Infections microbiology, Comorbidity, Humans, Male, Ohio, Treatment Outcome, Vancomycin therapeutic use, beta-Lactams therapeutic use, Anti-Bacterial Agents therapeutic use, Bacteremia drug therapy, Clostridioides difficile classification, Clostridioides difficile isolation & purification, Clostridium Infections drug therapy
- Abstract
Clostridium difficile bacteremia is rare. Here, we report two cases of C. difficile bacteremia in patients with significant underlying gastrointestinal pathology. In one case, the bacteremia was caused by the North American pulsed-field gel electrophoresis (PFGE) type 1 (NAP-1) strain, which is responsible for recent outbreaks of C. difficile infections of increased severity.
- Published
- 2011
- Full Text
- View/download PDF